Background: Chryseobacterium is an environmental inhabitant which is periodically discovered in human specimens. It is one of the prominent pathogens among non-fermentative Gram-negative bacilli. The members of Chryseobacterium genus are mainly noted for their multi-drug resistance. Materials and Methods: Patients admitted in tertiary care centre were examined for 6 months. Chryseobacterium species were isolated from different clinical samples using conventional methods (according to CLSI guidelines) and antibiotic susceptibility patterns were obtained. This study also comprised of associated underlying risk factors, comorbidities and eventually the treatment outcome. Results: A total of 9 isolates of C. indologenes were recovered from specific samples like urine, sputum, pus and ascitic fluid. Among which, four patients had respiratory tract infection, one had chronic liver disease, two had wound infection and in other two, the organism was isolated from the sample of catheterized urine. The two patients were in the intensive care unit and had central lines and indwelling catheter. The common underlying risk factors identified were diabetes, hypertension and coronary artery disease. Conclusion: This case concludes that C. indologenes may cause symptomatic disease in immunocompetent persons with otherwise no associated underlying risk factors.
Introduction:
Chryseobacterium is an environmental inhabitant that is usually identified in human specimens. Chryseobacterium species, which was formerly known as Flavobacterium, are aerobic, oxidasepositive, glucose non-fermenting, Gramnegative rods 1 . It is one of the emerging pathogens among non-fermentative Gram-negative bacilli. It has been isolated from patients with bacteraemia, meningitis, pneumonia, peritonitis, ocular infections and other long-term indwelling devices. The members of Chryseobacterium genus are known for their multi-drug resistance. 2 The risk factors for Chryseobacterium infection vary from hospitalization, cancer, immunosuppression, diabetes mellitus to prolonged antibiotic therapy (>14 days). 3 Chryseobacterium meningosepticum and Chryseobacterium indologenes are the two species generally isolated from clinical specimens.
Chryseobacterium indologenes species was primarily isolated in 1993 from the tracheal aspirate of a patient with ventilator-associated pneumonia 4 . Majority of the cases of C. indologenes were reported from long-term hospitalised patients on mechanical support associated with the underlying disease. The present case study was targeted to quantify the burden of C. indologenes infections among the patients admitted in different disciplines. The main aim of the present study was to isolate Chryseobacterium species from various clinical samples and the determination of its antibiotic sensitivity patterns.
Materials and Methods:
The patients admitted in tertiary care centre were examined for 6 months from November 2017 to April 2018. 
Results:
A total of 9 isolates of C. indologenes were recovered from different samples (one from ascitic fluid, two from pus, three from respiratory secretions like sputum and other three from urine). 
C. indologenes in various age groups:
The age groups are in the range of 17 yrs to 70 yrs All isolates were resistant to Carbapenems (intrinsically resistant) and Polymixin B.
One isolate from urine sample was multidrug resistant.
Antibiotic used in the treatment of C.indologenes infection
Third generation cephalosporins (55.56%) were the most commonly used antibiotic for the treatment of C.indologenes infection followed by Ciprofloxacin (33.3%) and Gentamicin (22.2%).
Discussion:
The primary identification of C. indologenes isolates was reasoned by their yellow pigmentation, oxidase positive and Polymixin B resistance. C. indologenes is easily distinguished from other nonfermenters by its individual ability to produce indole. 6 In the present study, 9 isolates of C. indologenes were recovered from various samples like ascitic fluid, respiratory secretions and urine which were correlated with the study conducted by Kaur H et al 2 and Vidhi Jain et al. 7 The isolate of C. indologenes from ascitic fluid was from a chronic liver disease patient and it was accounted as a true pathogen. Most of the other isolates were from ward patients in this study. 8 . In this study, the highest frequency of C.indologenes infection occurred among the elderly patients > 40years of age and the lowest frequency occurred among < 20 years of age. The main risk factors associated are diabetes, hypertension and coronary artery disease. According to the SENTRY Anti-microbial Surveillance Program results, the effective antibiotics against C. indologenes are quinolones (gatifloxacin and levofloxacin) and sulphamethoxazole-trimethoprim (≥ 95% sensitivity), followed by piperacillintazobactam (90% sensitivity) 9 . Majority of the isolates in this study were highly susceptible to piperacillin-tazobactam (77.78%) followed by Ceftazidime (66.67%). One of the isolates from catheterised urine sample was multi-drug resistant and it was correlated with the study done by Palewar MS, Mudshingkar SS et al in 2016. 10 The resistance to multiple antibiotics by C.indologenes was observed and confirmed in this study. As a conclusion, C. indologenes should be recognized as an emerging nosocomial pathogen. Its association with indwelling
